Get started
Author

Lynn D. Hudson

Observed names: Hudson, Lynn D, L D Hudson, L Hudson, L. D. Hudson, L. HUDSON, L. Hudson, L.D. Hudson, LD Hudson, LYNN D. HUDSON, Lynn D Hudson, Lynn Hudson
Observed institutions: California Institute of Technology, National Institutes of Health, Cleveland Clinic, National Multiple Sclerosis Society, Harvard University, Johns Hopkins University, Genentech, George Washington University, Brown University, Critical Path Institute, Massachusetts General Hospital, National Institute of Diabetes and Digestive and Kidney Diseases, Wave Life Sciences (United States), National Institute of Neurological Disorders and Stroke, UK Dementia Research Institute, National Institute of Allergy and Infectious Diseases, Imperial College London, University of Virginia, New York University, Amsterdam UMC Location Vrije Universiteit Amsterdam
OpenAlex ID: A5060998172
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
2017 · Ralph HB Benedict, John DeLuca, et al. · Multiple Sclerosis Journal · 882
Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ)
2000 · Jeffrey M. Peters, Susanna S. T. Lee, et al. · Molecular and Cellular Biology · 631
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
2017 · Peter Feys, Ilse Lamers, et al. · Multiple Sclerosis Journal · 526
PDF
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
2017 · Robert W Motl, Jeffrey A Cohen, et al. · Multiple Sclerosis Journal · 413
PDF
Emergence of three myelin proteins in oligodendrocytes cultured without neurons.
1986 · M Dubois-Dalcq, T Behar, et al. · The Journal of Cell Biology · 339
Alternative splicing accounts for the four forms of myelin basic protein
1985 · Francesca de Ferra, Helen Engh, et al. · Cell · 301
Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing Oligodendrocytes
2008 · Pierre Lau, Jonathan D. Verrier, et al. · Journal of Neuroscience · 252
PDF
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
2018 · Lauren Strober, John DeLuca, et al. · Multiple Sclerosis Journal · 239
PDF
Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination.
1992 · S Komoly, L D Hudson, et al. · Proceedings of the National Academy of Sciences · 223
Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis.
1995 · D L Yao, X Liu, et al. · Proceedings of the National Academy of Sciences · 213
Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder.
1989 · L D Hudson, C Puckett, et al. · Proceedings of the National Academy of Sciences · 205
Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse.
1987 · L D Hudson, J A Berndt, et al. · Proceedings of the National Academy of Sciences · 174
FAIR data sharing: The roles of common data elements and harmonization
2020 · R.D. Kush, D. Warzel, et al. · Journal of Biomedical Informatics · 169
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
2017 · Laura J Balcer, Jenelle Raynowska, et al. · Multiple Sclerosis Journal · 167
PDF
Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein.
1989 · S Gencic, D Abuelo, et al. · Europe PMC (PubMed Central) · 166
Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease.
1991 · W H Raskind, C A Williams, et al. · PubMed · 153
Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation.
1986 · S M Molineaux, H Engh, et al. · Proceedings of the National Academy of Sciences · 142
PDF
Tubulin polymerization‐promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation
2009 · Attila Lehotzky, Pierre Lau, et al. · Glia · 132
A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor.
1994 · F. Bogazzi, L.D. Hudson, et al. · Journal of Biological Chemistry · 132
PDF
Plasticity in the adult human oligodendrocyte lineage
1994 · N Gogate, L Verma, et al. · Journal of Neuroscience · 121
PDF
A point mutation in the proteolipid protein gene of the ‘shaking pup’ interrupts oligodendrocyte development
1990 · Nancy L. Nadon, Ian D. Duncan, et al. · Development · 118
Myt1 family recruits histone deacetylase to regulate neural transcription
2005 · Elena Romm, Joseph A. Nielsen, et al. · Journal of Neurochemistry · 115
Novel Member of the Zinc Finger Superfamily: A C2-HC Finger That Recognizes a Glia-Specific Gene
1992 · J G Kim, L D Hudson · Molecular and Cellular Biology · 115
Myelin transcription factor 1 (Myt1) modulates the proliferation and differentiation of oligodendrocyte lineage cells
2003 · Joseph A Nielsen, Jo Ann Berndt, et al. · Molecular and Cellular Neuroscience · 108
Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system
1997 · Jin G. Kim, Regina C. Armstrong, et al. · Journal of Neuroscience Research · 107
Works count: 99
Citation count: 8,977
H-index: 51
I10-index: 79
Year
Topic
Type